Recommended Topic Related To:

Imogam Rabies

"The U.S. Food and Drug Administration today approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.

Bexsero is the second vaccine approved"...

Imogam Rabies

PATIENT INFORMATION

Patients, parents or guardians should be fully informed by their health-care provider of the benefits and risks of administration of Imogam® Rabies – HT (rabies immune globulin (human)) .

Patients, parents or guardians should be instructed to report any serious adverse reactions to their health-care provider.

Last reviewed on RxList: 10/23/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.